We are live on ! Find out more
TLIS

Talis Biomedical Corporation Common Stock

Delisted

TLIS was delisted on the 30th of August, 2024.

Name Holding Trade Value Shares
Change
Change in
Stake
BBA
1
Baker Bros. Advisors
New York
$3.66M
GC
2
Greenlight Capital
New York
$1.07M
Vanguard Group
3
Vanguard Group
Pennsylvania
$224K -$2.46K -339 -1%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$67.5K -$1.88K -259 -3%
Millennium Management
5
Millennium Management
New York
$43.9K -$34.9K -4,813 -44%
BlackRock
6
BlackRock
New York
$36.6K -$2.98K -411 -7%
Morgan Stanley
7
Morgan Stanley
New York
$29.7K +$486 +67 +2%
Renaissance Technologies
8
Renaissance Technologies
New York
$26K +$6K +827 +29%
TSS
9
Two Sigma Securities
New York
$23.5K +$23.7K +3,267 New
State Street
10
State Street
Massachusetts
$22.8K -$1.02K -140 -4%
Deutsche Bank
11
Deutsche Bank
Germany
$21.7K -$7.17K -988 -25%
Citadel Advisors
12
Citadel Advisors
Florida
$18.7K +$18.8K +2,592 New
Northern Trust
13
Northern Trust
Illinois
$13.4K
Susquehanna International Group
14
Susquehanna International Group
Pennsylvania
$5.03K +$5.07K +698 New
Tudor Investment Corp
15
Tudor Investment Corp
Connecticut
$4.8K
Osaic Holdings
16
Osaic Holdings
Arizona
$751
TRCT
17
Tower Research Capital (TRC)
New York
$131 -$123 -17 -49%
LFG
18
Larson Financial Group
Missouri
$96
Wells Fargo
19
Wells Fargo
California
$84 +$7 +1 +9%
UBS Group
20
UBS Group
Switzerland
$12
NECFA
21
New England Capital Financial Advisors
Connecticut
$5
ACH
22
ArrowMark Colorado Holdings
Colorado
-$235K -31,924 Closed
PCM
23
Prelude Capital Management
New York
-$110K -14,929 Closed
Mercer Global Advisors
24
Mercer Global Advisors
Colorado
-$39K -5,325 Closed
Royal Bank of Canada
25
Royal Bank of Canada
Ontario, Canada
+$15 +2 +25%